Novartis takes home rights to Lubris’ eye drug

7th April 2017 Uncategorised 0

Novartis has elected to exercise an option to in-license experimental eye drug ECF843 from US biopharma Lubris.

More: Novartis takes home rights to Lubris’ eye drug
Source: News